Rare case of choroidal hemorrhage complicated with hypertension due to chronic renal failure.

BACKGROUND: Choroidal hemorrhage is usually seen as expulsive hemorrhage related to surgical invasion and is rarely observed in the absence of surgery or trauma. In this report, we describe a case of choroidal hemorrhage caused by hypertension related to chronic renal failure. CASE: A 32-year-old man presented with sudden visual loss, eye pain and swelling in his left eye. He had a history of renal failure and hypertension. Eye examination demonstrated choroidal hemorrhage associated with ocular hypertension in his left eye and marked hypertensive retinopathy in his right eye. OBSERVATIONS: He was treated with hemodialysis and antihypertensive drugs. Upon repeat eye examinations, a gradual reabsorption of the choroidal hemorrhage was observed, although vitreous hemorrhage appeared in the left eye. The vitreous hemorrhage was treated with vitrectomy with the patient regaining good visual acuity post-surgery. CONCLUSIONS: This rare case suggests that patients with severe background disease need to be carefully observed.

[Mass screening for prostate cancer in Tokushima City: the results of 2001].

PURPOSE: Screening with prostate specific antigen (PSA) only to detect prostate cancer was started in Tokushima City from 2001 as one of health check lists. We evaluated the first year result. MATERIALS AND METHODS: Fifty-five years old or elder men living in Tokushima City who wants to measure serum PSA level to screen for prostate cancer were entered to screening program. The men whose PSA levels detected as over normal; range were recommended to visit to urologists for further examination to detect prostate cancer include prostate biopsy. The results of further examination were reported to Tokushima City and evaluated. RESULTS: The population of fifty-five or elder men in Tokushima City was 25,416 and 9,019 (35.5%) men were measured serum PSA levels. In 801 (8.9%) men, PSA levels were over normal range, and recommended further examination to detect prostate cancer. 451 (56.3%) men visited to urologists for further examination, and prostate biopsy was performed in 231 (51.2%) men. Finally, 121 men were diagnosed as prostate cancer, 52.1% of 231 men performed prostate biopsy, 26.7% of 451 men visited to urologist for further examination, 1.34% of 9,019 men measured serum PSA levels. Patient number for each clinical stages were 49 in B0, 16 in B1, 16 in B2, 29 in C, one in D1, and 10 in D2. Patients number in each age range were 3 in 55-59, 11 in 60-64, 22 in 65-69, 37 in 70-74, 33 in 75-79, 15 in 80 or elder. Patient number of Stage B and 74 years old or younger was 48 (39.7%). CONCLUSION: Prostate cancer was detected in 1.34% of 9,019 men who measured serum PSA levels, and early stage B was two thirds. PSA screening to detect prostate cancer as one of health check-lists in Tokushima City was useful to detect early prostate cancer.